Markets

RATIO ANALYSIS

You can view the ratio analysis for the last 5 years.

Aarey Drugs & Pharmaceuticals Ltd.

Dec 05 BSE 76.43 ( -4.02 -5.00%)

Volume11156

Prev. Close
80.45

Open Price
76.43

Today's Low / High

76.43 77.00

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

31.30 100.00

Dec 05 NSE 75.62( -3.21 -4.07%)

Volume51612

Prev. Close
78.83

Open Price
76.89

Today's Low / High

74.88 76.89

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

31.35 100.00

Standalone

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00

PER SHARE RATIOS

Basic EPS (Rs.)	1.42	1.67	1.49	2.72	2.79
Diluted EPS (Rs.)	1.42	1.67	1.49	2.72	2.79
Cash EPS (Rs.)	2.10	2.27	2.11	3.36	3.18
Book Value[Excl.RevalReserv]/Share (Rs.)	48.67	47.33	46.25	44.77	42.27
Book Value[Incl.RevalReserv]/Share (Rs.)	48.67	47.33	46.25	44.77	42.27
Revenue From Operations / Share (Rs.)	166.56	141.02	165.04	194.09	148.99
PBDIT / Share (Rs.)	4.47	4.07	4.12	5.52	4.98
PBIT / Share (Rs.)	3.78	3.46	3.50	4.74	4.59
PBT / Share (Rs.)	2.14	1.90	2.37	3.95	3.55
Net Profit / Share (Rs.)	1.41	1.67	1.49	2.58	2.79

PROFITABILITY RATIOS

PBDIT Margin (%)	2.68	2.88	2.49	2.84	3.34
PBIT Margin (%)	2.27	2.45	2.11	2.44	3.08
PBT Margin (%)	1.28	1.35	1.43	2.03	2.38
Net Profit Margin (%)	0.84	1.18	0.90	1.32	1.86
Return on Networth / Equity (%)	2.90	3.52	3.21	5.75	6.58
Return on Capital Employeed (%)	7.61	7.10	7.20	10.44	10.68
Return On Assets (%)	1.38	1.54	1.29	2.66	2.79
Long Term Debt / Equity (X)	0.01	0.02	0.03	0.00	0.00
Total Debt / Equity (X)	0.25	0.23	0.32	0.12	0.18
Asset Turnover Ratio (%)	1.60	1.33	1.56	2.06	1.63

LIQUIDITY RATIOS

Current Ratio (X)	1.78	1.70	1.61	1.74	1.65
Quick Ratio (X)	1.48	1.49	1.44	1.63	1.51
Inventory Turnover Ratio (X)	11.83	0.00	0.00	0.00	0.00

COVERAGE RATIOS

Interest Coverage Ratio (%)	2.73	2.61	3.65	7.01	4.79
Interest Coverage Ratio (Post Tax) (%)	1.86	2.07	2.32	4.27	3.68

VALUATION RATIOS

Enterprise Value (Cr.)	129.30	155.10	97.10	119.06	71.62
EV / Net Operating Revenue (X)	0.27	0.39	0.23	0.24	0.20
EV / EBITDA (X)	10.17	13.59	9.29	8.50	6.15
MarketCap / Net Operating Revenue (X)	0.20	0.31	0.14	0.21	0.15
Price / BV (X)	0.69	0.94	0.51	0.92	0.54
Price / Net Operating Revenue (X)	0.20	0.31	0.14	0.21	0.15
EarningsYield	0.04	0.03	0.06	0.06	0.12

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

PER SHARE RATIOS
Basic EPS (Rs.)	1.42
Diluted EPS (Rs.)	1.42
Cash EPS (Rs.)	2.10
Book Value[Excl.RevalReserv]/Share (Rs.)	48.67
Book Value[Incl.RevalReserv]/Share (Rs.)	48.67
Revenue From Operations / Share (Rs.)	166.56
PBDIT / Share (Rs.)	4.47
PBIT / Share (Rs.)	3.78
PBT / Share (Rs.)	2.14
Net Profit / Share (Rs.)	1.41
PROFITABILITY RATIOS
PBDIT Margin (%)	2.68
PBIT Margin (%)	2.27
PBT Margin (%)	1.28
Net Profit Margin (%)	0.84
Return on Networth / Equity (%)	2.90
Return on Capital Employeed (%)	7.61
Return On Assets (%)	1.38
Long Term Debt / Equity (X)	0.01
Total Debt / Equity (X)	0.25
Asset Turnover Ratio (%)	1.60
LIQUIDITY RATIOS
Current Ratio (X)	1.78
Quick Ratio (X)	1.48
Inventory Turnover Ratio (X)	11.83
COVERAGE RATIOS
Interest Coverage Ratio (%)	2.73
Interest Coverage Ratio (Post Tax) (%)	1.86
VALUATION RATIOS
Enterprise Value (Cr.)	129.30
EV / Net Operating Revenue (X)	0.27
EV / EBITDA (X)	10.17
MarketCap / Net Operating Revenue (X)	0.20
Price / BV (X)	0.69
Price / Net Operating Revenue (X)	0.20
EarningsYield	0.04